These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers]. Lin X, Tang X, Xu YH, Zhang Y, Zhang Y, He HB. Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452 [Abstract] [Full Text] [Related]
3. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo. Lin X, Wang J, Xu Y, Tang X, Chen J, Zhang Y, Zhang Y, Yang Z. Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718 [Abstract] [Full Text] [Related]
4. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release. Lu Y, Yu Y, Tang X. J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936 [Abstract] [Full Text] [Related]
5. Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process. An T, Choi J, Kim A, Lee JH, Nam Y, Park J, Sun Bk, Suh H, Kim CJ, Hwang SJ. Int J Pharm; 2016 Apr 30; 503(1-2):8-15. PubMed ID: 26899975 [Abstract] [Full Text] [Related]
6. Microparticles produced by the hydrogel template method for sustained drug delivery. Lu Y, Sturek M, Park K. Int J Pharm; 2014 Jan 30; 461(1-2):258-69. PubMed ID: 24333903 [Abstract] [Full Text] [Related]
12. Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation. Wang L, Zheng X, Wu F, Shen L, Lin X, Feng Y. Drug Deliv; 2018 Nov 30; 25(1):267-277. PubMed ID: 29334805 [Abstract] [Full Text] [Related]
13. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor. Desai KG, Mallery SR, Schwendeman SP. Pharm Res; 2008 Mar 30; 25(3):586-97. PubMed ID: 17891553 [Abstract] [Full Text] [Related]
15. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Hu Z, Liu Y, Yuan W, Wu F, Su J, Jin T. Colloids Surf B Biointerfaces; 2011 Aug 01; 86(1):206-11. PubMed ID: 21524893 [Abstract] [Full Text] [Related]
17. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres. Selmin F, Blasi P, DeLuca PP. AAPS PharmSciTech; 2012 Dec 01; 13(4):1465-72. PubMed ID: 23090111 [Abstract] [Full Text] [Related]
18. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats. Lu Y, Tang X, Cui Y, Zhang Y, Qin F, Lu X. Eur J Pharm Biopharm; 2008 Feb 01; 68(2):422-9. PubMed ID: 17614267 [Abstract] [Full Text] [Related]
19. Long-Lasting In Situ Forming Implant Loaded with Bupivacaine: Investigation on Polymeric and Non-Polymeric Carrier and Solvent Effect. Bazraee S, Mobedi H, Mashak A, Jamshidi A. Curr Drug Deliv; 2022 Feb 01; 19(1):157-166. PubMed ID: 34139983 [Abstract] [Full Text] [Related]